BEAM
Price
$27.98
Change
-$0.16 (-0.57%)
Updated
Dec 26 closing price
Capitalization
2.84B
65 days until earnings call
Intraday BUY SELL Signals
TLPPF
Price
$8.06
Change
+$0.38 (+4.95%)
Updated
Dec 26 closing price
Capitalization
2.67B
Intraday BUY SELL Signals
Interact to see
Advertisement

BEAM vs TLPPF

Header iconBEAM vs TLPPF Comparison
Open Charts BEAM vs TLPPFBanner chart's image
Beam Therapeutics
Price$27.98
Change-$0.16 (-0.57%)
Volume$1.01M
Capitalization2.84B
Telix Pharmaceutical
Price$8.06
Change+$0.38 (+4.95%)
Volume$2.85K
Capitalization2.67B
BEAM vs TLPPF Comparison Chart in %
View a ticker or compare two or three
VS
BEAM vs. TLPPF commentary
Dec 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Buy and TLPPF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 28, 2025
Stock price -- (BEAM: $27.98 vs. TLPPF: $8.06)
Brand notoriety: BEAM and TLPPF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 50% vs. TLPPF: 94%
Market capitalization -- BEAM: $2.84B vs. TLPPF: $2.67B
BEAM [@Biotechnology] is valued at $2.84B. TLPPF’s [@Biotechnology] market capitalization is $2.67B. The market cap for tickers in the [@Biotechnology] industry ranges from $117.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileTLPPF’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • TLPPF’s FA Score: 1 green, 4 red.
According to our system of comparison, BEAM is a better buy in the long-term than TLPPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while TLPPF’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 5 bearish.
  • TLPPF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both BEAM and TLPPF are a good buy in the short-term.

Price Growth

BEAM (@Biotechnology) experienced а +5.31% price change this week, while TLPPF (@Biotechnology) price change was +3.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.36%. For the same industry, the average monthly price growth was +0.27%, and the average quarterly price growth was +54.56%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (+0.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.84B) has a higher market cap than TLPPF($2.67B). BEAM YTD gains are higher at: 12.823 vs. TLPPF (-46.177). TLPPF has higher annual earnings (EBITDA): 41.7M vs. BEAM (-434.55M). BEAM has more cash in the bank: 1.08B vs. TLPPF (207M). BEAM has less debt than TLPPF: BEAM (151M) vs TLPPF (418M). TLPPF has higher revenues than BEAM: TLPPF (638M) vs BEAM (55.7M).
BEAMTLPPFBEAM / TLPPF
Capitalization2.84B2.67B106%
EBITDA-434.55M41.7M-1,042%
Gain YTD12.823-46.177-28%
P/E RatioN/A345.69-
Revenue55.7M638M9%
Total Cash1.08B207M519%
Total Debt151M418M36%
FUNDAMENTALS RATINGS
BEAM vs TLPPF: Fundamental Ratings
BEAM
TLPPF
OUTLOOK RATING
1..100
1950
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
97
Overvalued
PROFIT vs RISK RATING
1..100
10069
SMR RATING
1..100
9790
PRICE GROWTH RATING
1..100
4088
P/E GROWTH RATING
1..100
1008
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BEAM's Valuation (33) in the null industry is somewhat better than the same rating for TLPPF (97). This means that BEAM’s stock grew somewhat faster than TLPPF’s over the last 12 months.

TLPPF's Profit vs Risk Rating (69) in the null industry is in the same range as BEAM (100). This means that TLPPF’s stock grew similarly to BEAM’s over the last 12 months.

TLPPF's SMR Rating (90) in the null industry is in the same range as BEAM (97). This means that TLPPF’s stock grew similarly to BEAM’s over the last 12 months.

BEAM's Price Growth Rating (40) in the null industry is somewhat better than the same rating for TLPPF (88). This means that BEAM’s stock grew somewhat faster than TLPPF’s over the last 12 months.

TLPPF's P/E Growth Rating (8) in the null industry is significantly better than the same rating for BEAM (100). This means that TLPPF’s stock grew significantly faster than BEAM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BEAMTLPPF
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
73%
MACD
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
70%
Advances
ODDS (%)
Bullish Trend 7 days ago
76%
Bullish Trend 7 days ago
76%
Declines
ODDS (%)
Bearish Trend 12 days ago
85%
Bearish Trend 11 days ago
71%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
78%
Bullish Trend 3 days ago
75%
Aroon
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signal:
Gain/Loss:
TLPPF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRASX19.470.15
+0.78%
T. Rowe Price Asia Opportunities I
JIJRX15.820.01
+0.06%
JHancock International Dynamic Gr R6
MSGRX12.73-0.05
-0.39%
Meridian Small Cap Growth Institutional
CCCNX6.53-0.05
-0.76%
Center Coast Brookfield Midstream Foc I
FGKFX37.62-1.43
-3.66%
Fidelity Growth Company K6

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-0.57%
CRSP - BEAM
72%
Closely correlated
-2.87%
RXRX - BEAM
61%
Loosely correlated
-3.41%
NTLA - BEAM
61%
Loosely correlated
-1.56%
PRME - BEAM
59%
Loosely correlated
-1.96%
AXON - BEAM
57%
Loosely correlated
-1.24%
More

TLPPF and

Correlation & Price change

A.I.dvisor tells us that TLPPF and GLMD have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TLPPF and GLMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLPPF
1D Price
Change %
TLPPF100%
+4.95%
GLMD - TLPPF
25%
Poorly correlated
-1.73%
DNLI - TLPPF
24%
Poorly correlated
-0.71%
BEAM - TLPPF
24%
Poorly correlated
-0.57%
RXRX - TLPPF
23%
Poorly correlated
-3.41%
JANX - TLPPF
23%
Poorly correlated
-0.42%
More